Skip to content

Mid-term results of surgical aortic valve replacement with bioprostheses in hemodialysis patients

Mid-term results of surgical aortic valve replacement with bioprostheses in hemodialysis patients - Mid-term results of surgical aortic valve replacement with bioprostheses in hemodialysis patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000047410
Enrollment
60
Registered
2022-04-06
Start date
2021-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aortic stenosis

Interventions

surgical aortic valve replacement with bioprostheses

Sponsors

Dokkyo Medical University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who underwent SAVR-BP for HD patients with aortic stenosis at Dokkyo Medical University Hospital between July 2009 and December 2020 included.

Exclusion criteria

Exclusion criteria: patients who deemed inappropriate for aortic valve repair.

Design outcomes

Primary

MeasureTime frame
Five-year mortality risk factors

Countries

Japan

Contacts

Public ContactIkuko Shibasaki

Dokkyo Medical University School of Medicine Department of Cardiac and Vascular Surgery

sibasaki@dokkyomed.ac.jp0282861111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026